PY
Payden Equity Income Fund Adviser Cl
PYVAX · NASDAQ
$19.06 +0.00% (+$0.00)
1M -2.02%
Market Cap $1.35B
P/E Ratio 12.12x
Div. Yield 5.31%
ROE -
Piotroski F-Score Weak
2/9Valuation
49 /100
Fair P/B 2.12x
P/E 12.12x
P/S 147.16x
Growth
49 /100
Stable Book val. growth 1.19%
EPS growth 17.67%
Rev. growth 7.38%
Profitability
83 /100
Strong Op. margin 23.83%
Net margin 1,213.69%
FCF margin N/A
Quality
75 /100
Excellent Asset turnover 0.01x
ROA 17.26%
ROE N/A
Debt
42 /100
Moderate Current ratio 0.73x
Net debt/EBITDA N/A
Debt/Equity N/A
Stability
57 /100
Moderate EPS volatility 197.16%
Beta 0.78x
Profitable years 1
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PYVAX
Online
Sector
Financial Services
Industry
Asset Management - Income
CEO
-
Employees
-
Headquarters
Los Angeles